Business · 06/10/2003Updated: 10/17/2026 · 1 min read
FDA Corrects Comment Period for Over-the-Counter Antigingivitis/Antiplaque Drug Products
Summary
The Food and Drug Administration (FDA) is correcting an error in a document that extended the comment period for over-the-counter antigingivitis/antiplaque drug products, originally set to November 25, 2003, after the document was published in the Federal Register on August 25, 2003.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →